Washington, DC–(ENEWSPF)–December 1, 2014. Since taking office, President Obama and his Administration have seen a significant shift in the HIV epidemic, in the United States and in partner countries. More people living with HIV know their status, and more people are on antiretroviral medications. As a result, the number of[Read More…]
Science
Trial Postponed, New Judge Assigned in Widely Watched Federal Medical Marijuana Case of Kettle Falls Five
U.S. Senate expected to take up measure restricting Justice Department funding for such prosecutions later this week Spokane, WA –(ENEWSPF)—December 1, 2014. A new judge assigned to hear the widely watched federal medical marijuana case of the Kettle Falls Five has continued the federal trial scheduled to begin today in[Read More…]
NASA’s Orion Flight Test and the Journey to Mars
The first future human mission to Mars and those that follow will require the ingenuity and dedication of an entire generation. We take the next step on that journey with the uncrewed, first flight test of Orion. Image Credit: NASA Washington, DC–(ENEWSPF)–December 1, 2014. In the not-too-distant future, astronauts destined[Read More…]
NOAA Issues Atlantic Tuna Management Measures
Amendment 7 aims to reduce bycatch discards Regulations announced today will help Atlantic bluefin tuna (above) in the Gulf of Mexico and off Cape Hatteras. (Credit: NOAA) Washington, DC–(ENEWSPF)–December 1, 2014. NOAA Fisheries today announced final regulations that will help protect Atlantic bluefin tuna by reducing dead discards and providing measures to help[Read More…]
Nearly 55 Percent of U.S. Infants Sleep with Potentially Unsafe Bedding
NIH, CDC study shows unsafe infant bedding use still common, despite warnings Bethesda, Maryland–(ENEWSPF)–December 1, 2014. Nearly 55 percent of U.S. infants are placed to sleep with bedding that increases the risk of sudden infant death syndrome, or SIDS, despite recommendations against the practice, report researchers at the National Institutes[Read More…]
Public Interest and Environmental Groups Call for More Aggressive EPA Rule to Curb Carbon Emissions
125 groups send letter to president outlining ways to strengthen proposal to curb climate change WASHINGTON, D.C. –(ENEWSPF)—December 1. 2014. More than 100 groups today called for more aggressive action by the U.S. Environmental Protection Agency’s to curb carbon emissions from existing power plants. In a letter organized by the Climate[Read More…]
‘We Must Leave No One Behind’ to End AIDS by 2030, UN Secretary General Ban Declares on World AIDS Day
World AIDS Day 2014. Source: UNAIDS NEW YORK–(ENEWSPF)–1 December 2014 – Ending the AIDS epidemic by 2030 requires a comprehensive approach that includes social justice, the democratization of science, gender equity, and a people-centred approach to health, said United Nations Secretary-General Ban Ki-moon on World AIDS Day, as he spotlighted[Read More…]
Colorado: Health Officials Recommend $7.5 Million In Grant Funding For Clinical Cannabis Trials
COLORADO—(ENEWSPF)—November 28, 2014. By Paul Armentano, NORML Deputy Director State Public Health Department officials have recommended over $7 million dollars in grant funding to pay for a series of state-sponsored clinical trials to assess the safety and efficacy of cannabis and cannabinoids. The proposed studies include a pair of clinical[Read More…]
‘The World is On the Side of Those Who Are Involved in This Fight’ Against Ebola – UN Envoy
Anthony Banbury, Head of the UN Mission for Ebola Emergency Response (UNMEER) and Dr. David Nabarro, Special Envoy on Ebola, at a joint interview. Photo: UNMEER GHANA–(ENEWSPF)–28 November 2014 – The top United Nations officials leading the fight against Ebola have made an appeal for people who possess skills that[Read More…]
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response
Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine Bethesda, Maryland–(ENEWSPF)–November 28, 2014. An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a phase 1 clinical trial conducted by researchers from[Read More…]
